blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3935172

EP3935172 - T CELL RECEPTORS AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  10.12.2021
Database last updated on 25.09.2024
FormerThe international publication has been made
Status updated on  11.09.2020
Most recent event   Tooltip28.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
University Health Network
190 Elizabeth Street
R. Fraser Elliott Building - Room 1S-417
Toronto, Ontario M5G 2C4 / CA
[2022/02]
Inventor(s)01 / HIRANO, Naoto
190 Elizabeth Street R. Fraser Elliott Building
Room 1S-417
Toronto, Ontario M5G-2C4 / CA
02 / MURATA, Kenji
190 Elizabeth Street R. Fraser Elliott Building
Room 1S-417
Toronto, Ontario M5G-2C4 / CA
03 / SASO, Kayoko
190 Elizabeth Street R. Fraser Elliott Building
Room 1S-417
Toronto, Ontario M5G-2C4 / CA
[N/P]
Former [2022/02]01 / HIRANO, Naoto
Toronto, Ontario M5G-2C4 / CA
02 / MURATA, Kenji
Toronto, Ontario M5G-2C4 / CA
03 / SASO, Kayoko
Toronto, Ontario M5G-2C4 / CA
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2022/02]
Application number, filing date20765650.503.03.2020
[2022/02]
WO2020IB51813
Priority number, dateUS201962813651P04.03.2019         Original published format: US 201962813651 P
[2022/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020178744
Date:10.09.2020
Language:EN
[2020/37]
Type: A1 Application with search report 
No.:EP3935172
Date:12.01.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 10.09.2020 takes the place of the publication of the European patent application.
[2022/02]
Search report(s)International search report - published on:CA10.09.2020
(Supplementary) European search report - dispatched on:EP28.11.2022
ClassificationIPC:C12N15/62, A61K31/675, A61K31/7076, A61K35/12, A61K35/17, A61K38/20, A61P35/00, C07F9/6584, C07K14/705, C07K14/725, C07K14/74, C07K19/00, C12N15/113, C12N15/12, C12N15/55, C12N15/867, C12N5/0783, C12N5/10, G01N33/566
[2022/02]
CPC:
C07K14/70539 (EP,IL,KR,US); C07K14/7051 (EP,IL,KR,US); A61K2239/57 (EP,IL,US);
A61K31/713 (EP,IL); A61K35/17 (KR); A61K38/20 (EP,IL);
A61K39/001192 (EP,IL,US); A61K39/4611 (EP,IL,US); A61K39/4632 (EP,IL,US);
A61K39/464492 (EP,IL,US); A61K45/06 (EP,IL); A61K48/00 (EP,IL);
A61P35/00 (EP,IL,KR); C07K16/2809 (EP,IL,KR,US); C07K16/2896 (EP,IL,US);
C07K16/30 (KR); C12N15/1138 (EP,IL,KR); C12N15/62 (EP,IL,US);
C12N5/0636 (EP,IL,KR,US); C12N9/22 (KR); G01N33/5011 (EP,IL);
G01N33/505 (EP,IL); A61K2300/00 (IL); C07K2317/31 (EP,IL,KR,US);
C07K2317/622 (EP,IL,KR,US); C07K2318/20 (EP,IL); C07K2319/03 (EP,IL,KR,US);
C12N2310/14 (EP,IL,KR); C12N2320/31 (EP,IL); C12N2330/50 (EP,IL);
C12N2510/00 (EP,IL,KR); C12N2740/10043 (EP,IL,US); C12N2740/13043 (KR) (-)
C-Set:
A61K31/713, A61K2300/00 (EP);
A61K38/20, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/02]
TitleGerman:T-ZELLREZEPTOREN UND VERFAHREN ZUR VERWENDUNG DAVON[2022/02]
English:T CELL RECEPTORS AND METHODS OF USE THEREOF[2022/02]
French:RÉCEPTEURS DE LYMPHOCYTES T ET LEURS PROCÉDÉS D'UTILISATION[2022/02]
Entry into regional phase09.09.2021National basic fee paid 
09.09.2021Search fee paid 
09.09.2021Designation fee(s) paid 
09.09.2021Examination fee paid 
Examination procedure09.09.2021Examination requested  [2022/02]
26.06.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
03.11.2021Renewal fee patent year 03
27.03.2023Renewal fee patent year 04
27.03.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]CA2674445  (US GOV HEALTH & HUMAN SERV [US]);
 [Y]WO2009051555  (AKADEMISCH ZIEKENHUIS LEIDEN [NL], et al);
 [Y]US2012082692  (KOSMATOPOULOS KOSTANTINOS KOSTAS [FR], et al);
International search[X]WO2010112962  (VAXON BIOTECH [FR], et al);
 [X]WO2011140284  (HUTCHINSON FRED CANCER RES [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.